Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor

Cytotherapy ◽  
2011 ◽  
Vol 13 (4) ◽  
pp. 459-466 ◽  
Author(s):  
Isabel Taubert ◽  
Rainer Saffrich ◽  
Abraham Zepeda-Moreno ◽  
Isabelle Hellwig ◽  
Volker Eckstein ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem

scholarly journals Hematopoietic Stem Cell Transplant As Consolidation Treatment in Multiple Myeloma in Ecuador

2021 ◽  
Vol 27 (3) ◽  
pp. S444-S445
Author(s):  
Bella Maldonado-Guerrero ◽  
Mayhua Lam-Rodríguez ◽  
Julie Abifandi-Valverde ◽  
Migleth Cisneros-López ◽  
Ana Thur de Koos-Acosta ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Consolidation Treatment

scholarly journals Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma

2020 ◽  
Vol 09 (04) ◽  
pp. 233-235
Author(s):  
Rahul Naithani ◽  
Nitin Dayal ◽  
Reeta Rai
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Young Patients ◽  
Cell Transplant ◽  
Hematopoietic Stem ◽  
Platelet Recovery

Abstract Introduction Multiple myeloma (MM) in very young patients is uncommon, and no treatment guidelines exist for these patients. Patients and Methods We performed a retrospective analysis of five very young myeloma patients who underwent tandem autologous hematopoietic stem cell transplantation (HSCT). Results The median age was 37 years (range = 34–40 years). A median of two leukapheresis was performed (range = 1–4). The median number of hematopoietic stem cells collected was 5.4 × 106/kg (4.4–8.2 × 106/kg). During first transplant, four patients received melphalan of 200 mg/m2 and one patient received melphalan of 140 mg/m2 (due to renal failure) as conditioning regimen. Second transplant conditioning was melphalan of 200 mg/m2 for one patient and melphalan of 140 mg/m2 for remaining four patients. Two patients were in complete remission, and two were in very good partial remission and one patient progressed to active disease at the time of tandem autologous bone marrow transplant. All patients developed significant mucositis. Neutrophil and platelet recovery was longer in tandem autologous hematopoietic stem cell transplant. More viral infections were seen in tandem transplant. Day 30 and day 100 mortality was nil. Conclusion We present data on tandem autologous HSCTs in very young patients with MM in India. Responses continued to improve in this small series.

Characterization of the new HLA‐B *35:482 , detected in a potential hematopoietic stem cell donor

HLA ◽  
2020 ◽  
Author(s):  
Anastasiia Ananeva ◽  
Iuliia Sergeeva ◽  
Raushania Gaifullina ◽  
Elena Shagimardanova
Keyword(s):  
Stem Cell ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem ◽  
Cell Donor

scholarly journals Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant

Cancer ◽  
2013 ◽  
Vol 119 (23) ◽  
pp. 4188-4195 ◽  
Author(s):  
Desiree Jones ◽  
Elisabeth G. Vichaya ◽  
Xin Shelley Wang ◽  
Mary H. Sailors ◽  
Charles S. Cleeland ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Cognitive Impairment ◽  
Hematopoietic Stem Cell ◽  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Hematopoietic Stem

scholarly journals Acute acquired Fanconi syndrome in multiple myeloma after hematopoietic stem cell transplantation

2020 ◽  
Author(s):  
Janina Paula T. Sy-Go ◽  
David Dingli ◽  
Morie A. Gertz ◽  
Prashant Kapoor ◽  
Francis K. Buadi ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Fanconi Syndrome ◽  
Hematopoietic Stem

Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy

2015 ◽  
Vol 96 (4) ◽  
pp. 417-424 ◽  
Author(s):  
Raúl Pérez ◽  
Mª Sol Durán ◽  
Jose Mayans ◽  
Alfons Soler ◽  
Inmaculada Castillo ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Hematopoietic Stem Cell Transplantation ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Hematopoietic Stem Cell ◽  
Clinical Features ◽  
Conventional Chemotherapy ◽  
Hematopoietic Stem
Sign in / Sign up

Export Citation Format

Share Document